Subscribe to MedHeadlinesNews FeedSubscribe to MedHeadlinesComments

Common Schizophrenia Drug on Trial

March 8, 2008 by MedHeadlines  
Filed under Bipolar Disorder, Diabetes, Drugs, FDA, Prevention, Schizophrenia

8 Comments

The pharmaceutical giant, Eli Lilly, is being sued by the state of Alaska over allegedly covering up the potential risks of Zyprexa (olanzapine). Attorneys for the state argue that the company knew that the drug, approved for the treatment of Schizophrenia and acute manic and mixed episodes of Bipolar Disorder, may cause diabetes in patients taking it. Read more

Tags: , ,

-->

Polls

  • In your opinion, should alternative medicine be regulated by the government?

    View Results

    Loading ... Loading ...

Editor's Picks

alt text Did Marrow Transplant Cure AIDS?

That’s the question abuzz in the medical community as doctors around the globe...

alt text Fan In Baby’s Room Reduces Risk of SIDS

One of the most heartbreaking and frustrating diagnoses discussed today is that of...

alt text Top Economist Says McCain’s Health Plan Better for More Americans

In a Wall Street Journal (WSJ) opinion piece, one of the nation’s top economists...

More Editor's Picks

Other Resources

    End, comment out -->

NEWS CATEGORIES